{
    "title": "J&J pulls COVID vaccine sales forecast due to low demand, supply glut",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10731247/Johnson--Johnson-suspends-sales-forecast-COVID-19-vaccine.html",
    "date": "2022-04-19",
    "keywords": [
        "vaccine",
        "jampj",
        "year",
        "income",
        "supply",
        "shot",
        "company",
        "business",
        "dividend",
        "quarter",
        "erman",
        "forecast",
        "hesitancy",
        "world",
        "demand",
        "covid",
        "europe",
        "wolk",
        "inc",
        "share",
        "currency",
        "growth",
        "reporting",
        "johnson",
        "tuesday",
        "covid19",
        "glut",
        "inoculation",
        "choice",
        "driving",
        "use",
        "production",
        "mixup",
        "contract",
        "manufacturer",
        "efficacy",
        "jampjs",
        "companys",
        "bit",
        "reticent",
        "g5",
        "respect",
        "officer",
        "joseph",
        "interview",
        "infrastructure",
        "refrigeration",
        "hurdle",
        "health",
        "organization",
        "poorer",
        "goal",
        "middle",
        "price",
        "pfizer",
        "se",
        "moderna",
        "profit",
        "move",
        "guidance",
        "forward",
        "analyst",
        "technology",
        "belief",
        "chain",
        "half",
        "bet",
        "healthcare",
        "sector",
        "unit",
        "street",
        "part",
        "jersey",
        "editing",
        "koyyur",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}